Allworth Financial LP Summit Therapeutics Inc. Transaction History
Allworth Financial LP
- $16.1 Billion
- Q3 2024
A detailed history of Allworth Financial LP transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Allworth Financial LP holds 1,022 shares of SMMT stock, worth $24,037. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,022
Previous 22
4545.45%
Holding current value
$24,037
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SMMT
# of Institutions
199Shares Held
76MCall Options Held
2.01MPut Options Held
2.84M-
Baker Bros. Advisors LP New York, NY24.4MShares$574 Million5.73% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.9MShares$257 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$186 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.44MShares$128 Million0.01% of portfolio
-
State Street Corp Boston, MA3.47MShares$81.6 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $4.73B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...